Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  MedPeer,Inc.    6095   JP3921240002

MEDPEER,INC.

(6095)
  Report
End-of-day quote. End-of-day quote Tokyo Stock Exchange - 03/05
5620 JPY   -0.71%
02/23MEDPEER,INC. : There is still some upside potential
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantOther languagesMarketScreener Strategies

MedPeer,Inc. : There is still some upside potential

02/23/2021 | 06:51am EST
long trade
Stop-loss triggered
Entry price : 6150¥ | Target : 8810¥ | Stop-loss : 5950¥ | Potential : 43.25%
MedPeer,Inc.'s shares display attractive technical aspects to anticipate a comeback of the underlying trend.
Investors have an opportunity to buy the stock and target the ¥ 8810.
MedPeer,Inc. : MedPeer,Inc. : There is still some upside potential
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.

Strengths
  • The prospective high growth for the next fiscal years is among the main assets of the company
  • The company returns high margins, thereby supporting business profitability.
  • Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
  • For the past twelve months, EPS forecast has been revised upwards.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 4325 JPY

Weaknesses
  • The group usually releases earnings worse than estimated.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 102.37 times its estimated earnings per share for the ongoing year.

© MarketScreener.com 2021

Haftungsausschluss: Die von Surperformance SAS, Herausgeber der Website marketscreener.com, veröffentlichten Analysen haben keinen vertraglichen Wert und stellen keine Aufforderung zum Kauf oder Verkauf von Wertpapieren oder anderen Finanzprodukten dar. Die auf der Website marketscreener.com dargestellten Beiträge und Inhalte sind von rein informativer Natur.
Das Unternehmen Surperformance, seine leitenden Angestellten und Mitarbeiter übernehmen keine Verantwortung für Fehler, Unterlassungen und Verluste bei Wertpapiergeschäften. Die auf der Website zur Verfügung gestellten Informationen, Grafiken, Abbildungen, Analysen und Kommentare richten sich ausschließlich an Anleger, die die erforderlichen Vorkenntnisse und Erfahrung mitbringen, um die Inhalte zu verstehen und richtig einordnen zu können. Die Inhalte werden zum Zweck von Information und Wissenserweiterung bereitgestellt. Obwohl Datenqualität für Surperformance eine absolute Priorität darstellt und das Unternehmen ausschließlich mit den weltweit führenden Datenlieferanten arbeitet, können wir keine Gewähr für die Richtigkeit der Daten übernehmen.

Financials
Sales 2021 7 795 M 72,0 M 72,0 M
Net income 2021 1 293 M 11,9 M 11,9 M
Net Debt 2021 - - -
P/E ratio 2021 93,5x
Yield 2021 -
Capitalization 121 B 1 118 M 1 118 M
Capi. / Sales 2021 15,5x
Capi. / Sales 2022 11,0x
Nbr of Employees 225
Free-Float 55,6%
Upcoming event on MEDPEER,INC.
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 7 293,33 JPY
Last Close Price 5 620,00 JPY
Spread / Highest target 59,8%
Spread / Average Target 29,8%
Spread / Lowest Target 8,54%
EPS Revisions
Managers and Directors
NameTitle
Yo Iwami President, CEO & Representative Director
Akinori Fukumura Chief Technology Officer & Executive Officer
Mitsuhiro Hayashi Chief Operating Officer & Director
Masatoshi Kawana Independent Non-Executive Outside Director
Masayuki Shimura Independent Non-Executive Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDPEER,INC.-31.13%1 118
ALPHABET INC.16.05%1 417 469
TENCENT HOLDINGS LIMITED20.39%832 857
FACEBOOK INC-5.68%752 582
ALIBABA GROUP HOLDING LIMITED0.50%632 696
VISA INC.-1.52%460 391